A critical discovery in cancer study is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer protector protein is frequently lost in various forms of malignancies, leading https://bookmarktune.com/story21832706/nanobodies-restore-the-p53-protein-the-promising-hope-for-tumor-management